Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05978960 · ClinicalTrials.gov registry record · NA

EXERT-BCN: an Exercise and Nutrition Regimen to Designed to Improve Body Composition After Treatment for Breast Cancer

A NA study, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

Completed
Registry status
NA
Development phase
44
Enrollment target

NCT05978960: Completed NA study, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

NCT05978960 is a NA study that has completed, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05978960, a NA study, has completed, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target

Study Summary

This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements in conjunction with a nutrition regimen focused on food quality under close supervision on women who have been treated for breast cancer.

Primary Outcome

Measurement on bioimpedance analysis machine (Inbody 970)

Interventions

  • OTHER Nutrition and resistance training exercise intervention

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2023-05-20
Est. Completion 2024-09-19
Phase NA

What the finished NCT05978960 record still lists

NCT05978960 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Nutrition and resistance training exercise intervention is the first listed.

NCT05978960 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05978960 about?

NCT05978960 is a clinical study titled "EXERT-BCN: an Exercise and Nutrition Regimen to Designed to Improve Body Composition After Treatment for Breast Cancer". This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements in conjunction with a nutrition regimen focused on food quality under close supervision on women who have been t...

What is the current status of trial NCT05978960?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2023-05-20. Estimated completion is 2024-09-19.

What interventions are being tested in trial NCT05978960?

The interventions under investigation include: Nutrition and resistance training exercise intervention (OTHER).

Who is sponsoring clinical trial NCT05978960?

This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05978960's enrollment target sits among peer trials

44 1423rd of 2000 higher than 566 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05978960, the US trial registry maintained by the National Library of Medicine. NCT05978960 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.